Our CEO Poul Sørensen shared our latest progress this morning at RNA Leaders in Vienna #RNATherapeutics #Pseudoexon #Parkinsons #Huntingtons #RNAleaders

Huntington’s disease is the best investment in neuroscience today www.sciencedirect.com/science/arti... #Huntingtons #Neuroscience #Investment

Exciting news from Inverna ! 🎉 www.linkedin.com/posts/invern... #RNATherapeutics #Pseudoexon #ASO #Innovation

Big news today! 🎉 #MJFF #RNAtherapeutics #Parkinsondisease #RNAsplicingmodulation #Pseudoexon #Innovation

🌟 Inverna is heading to JPM Week in SF! 🌟 Our CEO, Poul Sørensen, will share our vision for disease-modifying therapies for Huntington’s disease, powered by our RNA splicing platform. 📅 Attending too? Let’s connect to discuss partnerships and innovation! #jpm2025 #biotech #huntington #rnasplicing

Introducing Inverna Therapeutics, a next-gen RNA splicing platform tackling severe genetic diseases, starting with Huntington’s disease. Emerging from @argobiostudio.com and @sdu.dk, we're pioneering safer, more effective treatments for high unmet medical needs. www.argobiostudio.com/en/news/next...